Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,230 | -4,442 | -2,428 | -1,728 | -2,563 |
| Depreciation Amortization | 2,564 | 599 | 230 | 116 | 310 |
| Income taxes - deferred | 7,178 | N/A | N/A | N/A | 419 |
| Accounts receivable | 292 | -3,650 | -2,988 | -2,191 | -181 |
| Accounts payable and accrued liabilities | 83 | 2,873 | 1,219 | 1,531 | 624 |
| Other Working Capital | 1,619 | -801 | -1,794 | -674 | 5,702 |
| Other Operating Activity | 5,082 | 1,429 | 1,769 | 660 | -443 |
| Operating Cash Flow | $-4,412 | $-3,992 | $-3,992 | $-2,286 | $3,868 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -122 | -2 | -2 | N/A | -120 |
| Net Acquisitions | -6,753 | -2,423 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -38 | -16 | N/A | N/A | -66 |
| Other Investing Activity | -38 | -16 | 0 | 0 | -66 |
| Investing Cash Flow | $-6,913 | $-2,441 | $-2 | $N/A | $-186 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,315 | 2,288 | 2,454 | 1,479 | -2,315 |
| Debt Repayment | -1,143 | -1,085 | -974 | -935 | -1,208 |
| Common Stock Issued | 5,030 | 5,030 | 5,032 | N/A | N/A |
| Other Financing Activity | 3,915 | 919 | -1,756 | 3,475 | -200 |
| Financing Cash Flow | $12,117 | $7,152 | $4,756 | $4,019 | $-3,723 |
| Exchange Rate Effect | -76 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 11 | 11 | 11 | 11 | 52 |
| End Cash Position | 727 | 730 | 773 | 1,744 | 11 |
| Net Cash Flow | $716 | $719 | $762 | $1,733 | $-41 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,412 | -3,992 | -3,992 | -2,286 | 3,868 |
| Capital Expenditure | -122 | -2 | -2 | N/A | -120 |
| Free Cash Flow | -4,534 | -3,994 | -3,994 | -2,286 | 3,748 |